The global artificial intelligence (AI) in biotechnology market size accounted for USD 4.70 billion in 2024, grew to USD 5.60 billion in 2025, and is expected to be worth around USD 27.43 billion by 2034, poised to grow at a CAGR of 19.29% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence (AI) in Biotechnology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence (AI) in Biotechnology Market, by Offering, 2024-2034
8.1.1 Software
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Hardware
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Artificial Intelligence (AI) in Biotechnology Market, by Applications, 2024-2034
9.1.1. Drug Target Identification
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Drug Screening
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Image Screening
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Predictive Modeling
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Artificial Intelligence (AI) in Biotechnology Market, by Usage, 2024-2034
10.1.1. Agriculture Biotechnology
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Medical Biotechnology
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Animal Biotechnology
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Industrial Biotechnology
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Offering (2021-2034)
11.1.2. Market Revenue and Forecast, by Applications (2021-2034)
11.1.3. Market Revenue and Forecast, by Usage (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Offering (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Applications (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Usage (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Offering (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Applications (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Usage (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Offering (2021-2034)
11.2.2. Market Revenue and Forecast, by Applications (2021-2034)
11.2.3. Market Revenue and Forecast, by Usage (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Offering (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Applications (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Usage (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Offering (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Applications (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Usage (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Offering (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Applications (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Usage (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Offering (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Applications (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Usage (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Offering (2021-2034)
11.3.2. Market Revenue and Forecast, by Applications (2021-2034)
11.3.3. Market Revenue and Forecast, by Usage (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Offering (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Applications (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Usage (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Offering (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Applications (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Usage (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Offering (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Applications (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Usage (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Offering (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Applications (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Usage (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Offering (2021-2034)
11.4.2. Market Revenue and Forecast, by Applications (2021-2034)
11.4.3. Market Revenue and Forecast, by Usage (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Offering (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Applications (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Usage (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Offering (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Applications (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Usage (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Offering (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Applications (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Usage (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Offering (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Applications (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Usage (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Offering (2021-2034)
11.5.2. Market Revenue and Forecast, by Applications (2021-2034)
11.5.3. Market Revenue and Forecast, by Usage (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Offering (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Applications (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Usage (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Offering (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Applications (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Usage (2021-2034)
12.1. AstraZeneca
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Bristol-Myers Squibb
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Gilead Sciences, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Sanofi
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Abbott Laboratories
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Biogen
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Pfizer, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Novo Nordisk A/S
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Amgen, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Merck KGaA
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample